Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma

Purpose. To perform multivariate analysis for identifying independent predictors of elevated intraocular pressure (IOP) with neovascular glaucoma (NVG), including antivascular endothelial growth factor (VEGF) intravitreal injections. Methods. We retrospectively reviewed 142 NVG patients (181 eyes) w...

Full description

Saved in:
Bibliographic Details
Main Authors: Satoko Nakano, Takako Nakamuro, Katsuhiko Yokoyama, Kunihiro Kiyosaki, Toshiaki Kubota
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2016/1205895
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552670442815488
author Satoko Nakano
Takako Nakamuro
Katsuhiko Yokoyama
Kunihiro Kiyosaki
Toshiaki Kubota
author_facet Satoko Nakano
Takako Nakamuro
Katsuhiko Yokoyama
Kunihiro Kiyosaki
Toshiaki Kubota
author_sort Satoko Nakano
collection DOAJ
description Purpose. To perform multivariate analysis for identifying independent predictors of elevated intraocular pressure (IOP) with neovascular glaucoma (NVG), including antivascular endothelial growth factor (VEGF) intravitreal injections. Methods. We retrospectively reviewed 142 NVG patients (181 eyes) with ischemic retinal diseases [proliferative diabetic retinopathy (PDR) in 134 eyes, retinal vein occlusion (RVO) in 29, and ocular ischemic syndrome in 18]. We analyzed age, gender, initial/final LogMAR VA, initial/final IOP, extent of iris and/or angle neovascularization, treatments, preexisting complications, concurrent medications, and follow-up duration. Results. The mean follow-up duration was 23.8 ± 18.8 months. At the final follow-up, 125 (72.3%) eyes had IOP ≤ 21 mmHg. NVG patients with RVO had a higher degree of angle closure and higher IOP. NVG with PDR had better IOP and LogMAR VA. Angle closure had the greatest impact on final IOP. Greater than 90% of patients treated with trabeculectomy with mitomycin C (LEC) had persistent declines in IOP (≤21 mmHg). Stand-alone and combination anti-VEGF therapies were not associated with improved long-term prognosis of IOP. Conclusions. Angle closure was found to have the greatest effect on NVG-IOP prognosis. When target IOP values are not obtained after adequate PRP with or without anti-VEGF, early LEC may improve the prognosis of IOP.
format Article
id doaj-art-d1d5e69ff32c497796635cab2dbd2b68
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-d1d5e69ff32c497796635cab2dbd2b682025-02-03T05:58:14ZengWileyJournal of Ophthalmology2090-004X2090-00582016-01-01201610.1155/2016/12058951205895Prognostic Factor Analysis of Intraocular Pressure with Neovascular GlaucomaSatoko Nakano0Takako Nakamuro1Katsuhiko Yokoyama2Kunihiro Kiyosaki3Toshiaki Kubota4Department of Ophthalmology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, JapanDepartment of Ophthalmology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, JapanDepartment of Ophthalmology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, JapanDepartment of Ophthalmology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, JapanDepartment of Ophthalmology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, JapanPurpose. To perform multivariate analysis for identifying independent predictors of elevated intraocular pressure (IOP) with neovascular glaucoma (NVG), including antivascular endothelial growth factor (VEGF) intravitreal injections. Methods. We retrospectively reviewed 142 NVG patients (181 eyes) with ischemic retinal diseases [proliferative diabetic retinopathy (PDR) in 134 eyes, retinal vein occlusion (RVO) in 29, and ocular ischemic syndrome in 18]. We analyzed age, gender, initial/final LogMAR VA, initial/final IOP, extent of iris and/or angle neovascularization, treatments, preexisting complications, concurrent medications, and follow-up duration. Results. The mean follow-up duration was 23.8 ± 18.8 months. At the final follow-up, 125 (72.3%) eyes had IOP ≤ 21 mmHg. NVG patients with RVO had a higher degree of angle closure and higher IOP. NVG with PDR had better IOP and LogMAR VA. Angle closure had the greatest impact on final IOP. Greater than 90% of patients treated with trabeculectomy with mitomycin C (LEC) had persistent declines in IOP (≤21 mmHg). Stand-alone and combination anti-VEGF therapies were not associated with improved long-term prognosis of IOP. Conclusions. Angle closure was found to have the greatest effect on NVG-IOP prognosis. When target IOP values are not obtained after adequate PRP with or without anti-VEGF, early LEC may improve the prognosis of IOP.http://dx.doi.org/10.1155/2016/1205895
spellingShingle Satoko Nakano
Takako Nakamuro
Katsuhiko Yokoyama
Kunihiro Kiyosaki
Toshiaki Kubota
Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma
Journal of Ophthalmology
title Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma
title_full Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma
title_fullStr Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma
title_full_unstemmed Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma
title_short Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma
title_sort prognostic factor analysis of intraocular pressure with neovascular glaucoma
url http://dx.doi.org/10.1155/2016/1205895
work_keys_str_mv AT satokonakano prognosticfactoranalysisofintraocularpressurewithneovascularglaucoma
AT takakonakamuro prognosticfactoranalysisofintraocularpressurewithneovascularglaucoma
AT katsuhikoyokoyama prognosticfactoranalysisofintraocularpressurewithneovascularglaucoma
AT kunihirokiyosaki prognosticfactoranalysisofintraocularpressurewithneovascularglaucoma
AT toshiakikubota prognosticfactoranalysisofintraocularpressurewithneovascularglaucoma